Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

Published:2015-04-16 Issue:16 Volume:372 Page:1489-1499
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Robinson Jennifer G.,Farnier Michel,Krempf Michel,Bergeron Jean,Luc Gérald,Averna Maurizio,Stroes Erik S.,Langslet Gisle,Raal Frederick J.,El Shahawy Mahfouz,Koren Michael J.,Lepor Norman E.,Lorenzato Christelle,Pordy Robert,Chaudhari Umesh,Kastelein John J.P.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1501031

Cited by 1790 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive retrospect on biomarkers indicating vascular failure;Vascular Failure;2024-12-01

2. PCSK9 inhibition protects mice from food allergy;Translational Research;2024-10

3. PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention;Lipids in Health and Disease;2024-09-10

4. The journey to LDL-C goal in the era of combination lipid lowering therapy and why it matters for ASCVD patients: a UK perspective;Current Medical Research and Opinion;2024-09-09

5. Targeting the MHC-I endosomal-lysosomal trafficking pathway in cancer: From mechanism to immunotherapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP